Sarepta Therapeutics to Present Company Overview at the Needham Annual Healthcare Conference

Sarepta Therapeutics to Present Company Overview at the Needham Annual 
Healthcare Conference 
Webcast Accessible via Sarepta Therapeutics Website 
CAMBRIDGE, MA -- (Marketwired) -- 04/18/13 --  Sarepta Therapeutics
(NASDAQ: SRPT), a developer of innovative RNA-based therapeutics,
announced today that it is scheduled to present at the Needham &
Company Annual Healthcare Conference in New York, NY on Tuesday,
April 30, 2013 at 4:20 p.m. Eastern Time. Chris Garabedian, Sarepta's
president and CEO, will be the presenter.  
The presentation will be webcast live under the investor relations
section of Sarepta Therapeutics' website at
www.sareptatherapeutics.com and will be archived there following the
presentation for 90 days. Please connect to Sarepta's website several
minutes prior to the start of the broadcast to ensure adequate time
for any software download that may be necessary. 
About Sarepta Therapeutics 
Sarepta Therapeutics is focused on developing first-in-class
RNA-based therapeutics to improve and save the lives of people
affected by serious and life-threatening rare and infectious
diseases. The Company's diverse pipeline includes its lead program
eteplirsen, for Duchenne muscular dystrophy, as well as potential
treatments for some of the world's most lethal infectious diseases.
Sarepta aims to build a leading, independent biotech company
dedicated to translating its RNA-based science into transformational
therapeutics for patients who face significant unmet medical needs.
For more information, please visit us at www.sareptatherapeutics.com. 
Sarepta Investor Contact: 
Erin Cox 
857.242.3714 
ecox@sareptatherapeutics.com 
Sarepta Media Contact:
Jim Baker
857.242.3710
jbaker@sareptatherapeutics.com 
 
 
Press spacebar to pause and continue. Press esc to stop.